Norris Medicines Ltd. (NORRIS)
Market Open
11 Aug, 22:00
MSE MSE Primary ₹
16. 00
+0.65
+4.2345%
₹
129.71M Market Cap
- P/E Ratio
- Div Yield
1,036 Volume
0 Eps
₹ 15.35
Previous Close Want to track NORRIS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Norris Medicines Ltd. (NORRIS) Statistics
Valuation metrics
Market Cap 129.71M
Enterprise value 364.25M
Trailing P/E (ttm) -53.25
Forward P/E -
PEG ratio -0.68
Price/Sales (ttm) 1.83
Price/Book (mrq) -1
Enterprise Value/Revenue 4.48
Enterprise Value/EBITDA 51.42
Overview
Shares outstanding 10M
Float 2.39M
Shares short -
% Held by insiders 0.76%
% Held by institutions -
Average volume (10 days) 448
Average volume (90 days) 1.65K
Price summary
52-Week low 12
52-Week high 19.63
Beta -0.88
50-Day moving average 15.34
200-Day moving average 14.24
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:10
Last split Date 22 Aug 2013
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin -0.03%
Operating margin 0.27%
Operational effectiveness
Return on assets -0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) 94.44M
Revenue per share (ttm) 8.04
Quarterly revenue growth (yoy) 1.95%
Gross profit (ttm) 37.58M
EBITDA 4.74M
Net income to common (ttm) -5.6M
Diluted EPS (ttm) -0.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 646K
Total cash per share (mrq) 0.02
Total debt (mrq) 214.72M
Total Debt/Equity (mrq) -1.42
Current ratio (mrq) 0.61%
Book value per share (mrq) -14.97
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
